Aperio Group’s AstraZeneca AZN Stock Holding History

Aperio Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	$67.9M	Sell	1,359,053 -70,965	-5%	-$3.55M	0.2%	79
2020 Q3	$78.4M	Buy	1,430,018 +19,429	+1%	+$1.06M	0.26%	62
2020 Q2	$74.6M	Buy	1,410,589 +33,707	+2%	+$1.78M	0.28%	61
2020 Q1	$61.5M	Buy	1,376,882 +114,153	+9%	+$5.1M	0.27%	65
2019 Q4	$63M	Buy	1,262,729 +36,185	+3%	+$1.8M	0.23%	83
2019 Q3	$54.7M	Buy	1,226,544 +138,183	+13%	+$6.16M	0.22%	88
2019 Q2	$44.9M	Sell	1,088,361 -1,454	-0.1%	-$60K	0.18%	114
2019 Q1	$44.1M	Buy	1,089,815 +21,521	+2%	+$870K	0.19%	109
2018 Q4	$40.6M	Buy	1,068,294 +58,980	+6%	+$2.24M	0.2%	102
2018 Q3	$39.9M	Buy	1,009,314 +43,540	+5%	+$1.72M	0.18%	126
2018 Q2	$33.9M	Buy	965,774 +61,190	+7%	+$2.15M	0.16%	142
2018 Q1	$31.6M	Buy	904,584 +87,994	+11%	+$3.08M	0.16%	148
2017 Q4	$28.3M	Buy	816,590 +82,831	+11%	+$2.87M	0.14%	166
2017 Q3	$24.9M	Buy	733,759 +5,724	+0.8%	+$194K	0.14%	169
2017 Q2	$24.8M	Buy	728,035 +83,504	+13%	+$2.85M	0.15%	154
2017 Q1	$20.1M	Buy	644,531 +16,134	+3%	+$502K	0.14%	177
2016 Q4	$17.2M	Sell	628,397 -477,392	-43%	-$13M	0.13%	176
2016 Q3	$36.3M	Buy	1,105,789 +46,539	+4%	+$1.53M	0.26%	82
2016 Q2	$32M	Buy	1,059,250 +3,453	+0.3%	+$104K	0.25%	91
2016 Q1	$29.7M	Sell	1,055,797 -138,413	-12%	-$3.9M	0.25%	86
2015 Q4	$40.5M	Buy	1,194,210 +138,289	+13%	+$4.69M	0.37%	53
2015 Q3	$33.6M	Buy	1,055,921 +114,497	+12%	+$3.64M	0.34%	56
2015 Q2	$30M	Buy	941,424 +47,820	+5%	+$1.52M	0.31%	69
2015 Q1	$30.6M	Buy	893,604 +103,280	+13%	+$3.53M	0.34%	60
2014 Q4	$27.8M	Sell	790,324 -42,310	-5%	-$1.49M	0.34%	54
2014 Q3	$29.7M	Buy	832,634 +30,824	+4%	+$1.1M	0.4%	44
2014 Q2	$29.8M	Sell	801,810 -9,728	-1%	-$361K	0.43%	38
2014 Q1	$26.3M	Buy	+811,538	New	+$26.3M	0.37%	41
2013 Q4	–	Sell	-646,156	Closed	-$16.8M	–	50
2013 Q3	$16.8M	Buy	646,156 +106,686	+20%	+$2.77M	0.32%	53
2013 Q2	$12.8M	Buy	+539,470	New	+$12.8M	0.3%	57